Last reviewed · How we verify
NCT07362511: IMPACT MADE
Imagery Rescripting in Primary Care
NA trial testing Imagery Rescripting in Major Depressive Diorder in 12 participants. Currently enrolling.
31 August 2026
Quick facts
| Lead sponsor | University of Amsterdam |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 12 |
| Start date | 1 December 2025 |
| Primary completion | 31 August 2026 |
| Estimated completion | 31 January 2027 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- Imagery Rescripting
Conditions studied
- Major Depressive Diorder — all drugs for Major Depressive Diorder →
- Low Self-Esteem — all drugs for Low Self-Esteem →
- Mood Disorders — all drugs for Mood Disorders →
Sponsor
University of Amsterdam
Who can join
Adults 18 to 70, any sex, with Major Depressive Diorder or Low Self-Esteem. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In the current study we aim to investigate the feasibility, acceptability, and effectiveness of ImRs offered by mental health assistants within primary care to reduce depressive symptoms. In a single-case experimental design (SCED) study, the following hypotheses will be tested: 1. ImRs results in a reduction of depressive symptoms compared to baseline, and this reduction lasts up to six months. 2. Patients with complaints of depressive symptoms find ImRs an acceptable form of intervention when offered by mental health assistants within a general practice setting. Participants will wait for 2-4 weeks and then receive 5 sessions of ImRs over a period of 10 weeks. During these sessions, negative memories related to their depressed feelings are rescripted.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07362511
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Imagery Rescripting
Trials testing the same drug.
- NCT05976945 — Imagery Rescripting as Treatment for Depression · NA · recruiting
- NCT07196085 — Neural Mechanisms and Efficacy of Imagery Rescripting for Fear of Failure · NA · completed
- NCT07048756 — Psychotherapeutic Imagery Techniques · NA · completed
- NCT03607630 — Can Imagination Change Upsetting Memories of Trauma? · Phase 1, PHASE2 · unknown
Other recruiting trials for Major Depressive Diorder
Currently open trials in the same condition.
- NCT07281352 — RCT of Psilocybin-assisted CBT for Depression · Phase 1, PHASE2 · recruiting
- NCT06641726 — Creating a Global Research Database That Connects Genetic Information and Long-term Health Data to Improve Personalized · recruiting
- NCT06719427 — qEEG Brain Signature of Depression & Neuromodulation-induced Recovery · Phase 1 · recruiting
- NCT06728280 — Efficacy and Safety of DTMS in Adolescent Major Depressive Disorder · NA · recruiting
- NCT06616116 — Stress Management with Real-time Bio-signal Biofeedback · NA · recruiting
Other University of Amsterdam trials
Trials by the same sponsor.
- NCT07505238 — Informing Patients About Their Surgery's Environmental Impact: an Effective Pathway to Sustainable Healthcare? · NA · not yet recruiting
- NCT06966323 — Hold me Tight/Let me Go: Effectiveness of a Course to Enhance Parent-adolescent Relationship · recruiting
- NCT06336551 — Acceptance and Commitment Therapy for Insomnia · NA · completed
- NCT05986552 — The Influence of Treatment Format on Schema Therapy for Borderline Personality Disorder · NA · enrolling by invitation
- NCT05976945 — Imagery Rescripting as Treatment for Depression · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07362511 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Amsterdam
- Last refreshed: 23 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07362511.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing